These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 4038418

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synthesis and biochemical studies of analogs of platelet-activating factor bearing a methyl group at C2 of the glycerol backbone.
    Bittman R, Witzke NM, Lee TC, Blank ML, Snyder F.
    J Lipid Res; 1987 Jun; 28(6):733-8. PubMed ID: 3611974
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. On the synthesis of platelet-activating factor via acetylation of 1-alkyl-sn-glycero-3-phosphocholine. Formation of structural isomer of PAF in the presence of bases.
    Chupin VV, Ostapenko OV, Klykov VN, Anikin MV, Serebrennikova GA.
    Chem Phys Lipids; 1996 Jun 17; 81(1):35-43. PubMed ID: 9471401
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
    Blank ML, Spector AA, Kaduce TL, Lee TC, Snyder F.
    Biochim Biophys Acta; 1986 May 21; 876(3):373-8. PubMed ID: 3707974
    [Abstract] [Full Text] [Related]

  • 8. Synthesis of trideuterated O-alkyl platelet activating factor and lyso derivatives.
    Prakash C, Saleh S, Taber DF, Blair IA.
    Lipids; 1989 Sep 21; 24(9):786-92. PubMed ID: 2586235
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The enantiomer and the positional isomer of platelet-activating factor.
    Tence M, Coëffier E, Polonsky J, Benveniste J.
    Biochim Biophys Acta; 1983 Feb 22; 755(3):526-30. PubMed ID: 6824744
    [Abstract] [Full Text] [Related]

  • 11. Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.
    Komuro Y, Imanishi N, Uchida M, Morooka S.
    Mol Pharmacol; 1990 Sep 22; 38(3):378-84. PubMed ID: 2402227
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of synthetic phospholipids on platelet aggregation and serotonin release.
    Söling U, Eibl H, Nagel GA, Unger C.
    Lipids; 1987 Nov 22; 22(11):868-70. PubMed ID: 3444380
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Translocation of exogenous platelet-activating factor and its lyso-compound through plasma membranes is a rate-limiting step for their metabolic conversions into alkylacylglycerophosphocholines in rabbit platelets and guinea-pig leukocytes.
    Tokumura A, Tsutsumi T, Yoshida J, Tsukatani H.
    Biochim Biophys Acta; 1990 May 01; 1044(1):91-100. PubMed ID: 2340312
    [Abstract] [Full Text] [Related]

  • 19. Semisynthetic preparation of 1-O-hexadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet activating factor).
    Lekka ME, Tsoukatos DC, Tselepis AD, Kapoulas VM.
    Z Naturforsch C J Biosci; 1988 May 01; 43(9-10):665-70. PubMed ID: 3245264
    [Abstract] [Full Text] [Related]

  • 20. Conversion of 1-alkyl-2-acetyl-sn-glycerols to platelet activating factor and related phospholipids by rabbit platelets.
    Blank ML, Lee TC, Cress EA, Malone B, Fitzgerald V, Snyder F.
    Biochem Biophys Res Commun; 1984 Oct 15; 124(1):156-63. PubMed ID: 6497876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.